Does Intellia Therapeutics (NTLA) Pay a Dividend? (2026)
Short answer
Intellia Therapeutics (NTLA) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Intellia Therapeutics (NTLA) pay a dividend?
Intellia Therapeutics (NTLA) currently returns little or nothing as a dividend. Because Intellia has no product profits and only collaboration revenue, traditional earnings-based valuation multiples like P/E are negative and not analytically useful. The stock is better evaluated on its cash runway relative to its burn rate, the probability and timing of regulatory approval for lonvo-z and nex-z, and the risk-adjusted commercial potential of those programs. The April 2026 equity raise extended the stated runway at least into 2028, but pre-profit biotechs of this type typically require additional capital before reaching sustained profitability, so dilution and the binary nature of trial readouts are central to any valuation view.
How to think about NTLA's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like NTLA.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the NTLA dividend
Intellia Therapeutics (NTLA) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the NTLA guide. Walnut can show how NTLA fits your real portfolio. It is not an investment adviser.
Build a basket around NTLA with Walnut
Use Intellia Therapeutics as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Intellia Therapeutics (NTLA) pay a dividend?
+
Intellia Therapeutics (NTLA) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on NTLA's investor relations page.
What is NTLA's dividend yield?
+
NTLA's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does NTLA pay its dividend?
+
US companies that pay dividends, like Intellia Therapeutics if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on NTLA's investor relations page before relying on the timing.
Can I reinvest NTLA dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any NTLA dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is NTLA a good dividend stock?
+
Walnut is informational, not investment advice. NTLA is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does NTLA pay a dividend?
+
No. Intellia Therapeutics does not pay a dividend. As an unprofitable, pre-commercial biotech, the company directs all of its capital toward clinical development and operations rather than returning cash to shareholders. Investors seeking dividend income would need to look elsewhere in the healthcare or broader market, as any return from NTLA would have to come from share-price appreciation.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with NTLA's investor relations page or your broker.